...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant
【24h】

H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant

机译:通过免疫组织化学使用针对组蛋白H3.3变体的G34W突变位点的单克隆抗体来检测骨的巨细胞肿瘤的H3F3A突变。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims: Giant cell tumour of the bone (GCTB) is a neoplasm predominantly of long bones characterized by the H3F3A mutation G34W. Conventional diagnosis is challenged by the tumour's giant cell-rich morphology, which overlaps with other giant cell-containing lesions of the bone. Recently, a monoclonal antibody specific for the H3F3A mutation has been generated. Our aim was to test this antibody on a cohort of giant cell-containing lesions.
机译:目的:骨骼的巨细胞肿瘤(GCTB)是主要的肿瘤,其具有由H3F3A突变G34W的H3F3A突变的长骨骼。 常规诊断受到肿瘤的富含细胞的富含细胞形态的挑战,其与骨的其他含巨型细胞病变重叠。 最近,已经产生了对H3F3A突变的单克隆抗体。 我们的目的是在含巨型细胞病变的群体上测试该抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号